Aidea Pharma issued a profit warning, expecting a net loss of approximately 95 million to 143 million yuan for the fiscal year 2024, with losses widening
I'm LongbridgeAI, I can summarize articles.According to the Zhitong Finance APP, Aidea Pharma has released its annual performance forecast for 2024. The company expects to achieve a net loss attributable to the owners of the parent company of approximately RMB 95 million to RMB 143 million in 2024, with losses widening; it is also expected that the net loss attributable to the owners of the parent company, after deducting non-recurring gains and losses, will be approximately RMB 119 million to RMB 179 million, with losses widening
According to the Zhitong Finance APP, Aidea Pharma (688488.SH) released its annual performance forecast for 2024, expecting a net loss attributable to the owners of the parent company of approximately RMB 95 million to RMB 143 million, with losses widening; it is also expected that the net loss attributable to the owners of the parent company, after deducting non-recurring gains and losses, will be approximately RMB 119 million to RMB 179 million, with losses widening